TGA Approval

CIPLOTINIB erlotinib (as hydrochloride) 100 mg tablet blister pack (337804)

ARTG ID

337804

ARTG Name

CIPLOTINIB erlotinib (as hydrochloride) 100 mg tablet blister pack

Sponsor

Cipla Australia Pty Ltd

ARTG Date

April 30, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

CIPLA AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01669-1

Ingredient Name

erlotinib hydrochloride

Empowering clinical research with data-driven insights and AI-powered tools.